MENU

Fox Chase Cancer Center News

Hossein Borghaei, DO, MS, chief of Thoracic Medical Oncology
August 8, 2022

Tarlatamab Shows Efficacy Against Metastatic Small Cell Lung Cancer in Phase 1 Study

PHILADELPHIA (August 8, 2022)—Patients with metastatic small cell lung cancer (SCLC) have limited options for treatment, with few drugs available for patients who have already completed frontline chemotherapy and immunotherapy. Now a global multi-institutional study that included researchers from Fox Chase Cancer Center has shown that the investigational drug tarlatamab is a promising new potential treatment for SCLC.

Tomasz Skorski, MD, PhD, DSc, director of the Fels Cancer Institute and associate director at Fox Chase
August 4, 2022

Fels Cancer Institute for Personalized Medicine, Fox Chase Cancer Center, and Thomas Jefferson University to Host Inaugural Symposium on Genome Instability and Personalized Medicine

PHILADELPHIA (August 4, 2022)—The Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, in partnership with Fox Chase Cancer Center and Thomas Jefferson University, will host a free symposium, “Genome Instability: Discovery to Personalized Medicine.” This event will be held in person on Friday, October 14, 2022, at the DoubleTree by Hilton hotel in Philadelphia.

Dr. Adam Walchak, assistant professor in the Department of Surgical Oncology, Division of Plastic and Reconstructive Surgery
August 3, 2022

Fox Chase Cancer Center Welcomes Dr. Adam Walchak

PHILADELPHIA (August 3, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Adam Walchak, MD, MS, as an assistant professor in the Department of Surgical Oncology, where he will work in the Division of Plastic and Reconstructive Surgery.

Malorie K. Simons, MD, as an assistant professor in the Department of Gastroenterology
August 2, 2022

Fox Chase Cancer Center Welcomes Dr. Malorie K. Simons

PHILADELPHIA (August 2, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Malorie K. Simons, MD, as an assistant professor in the Department of Gastroenterology.

Jay Simhan, MD, FACS, who will join Fox Chase and the Temple Health community this summer
July 21, 2022

Fox Chase Cancer Center and Temple Health Welcome Urologist Dr. Jay Simhan

PHILADELPHIA (July 21, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Jay Simhan, MD, FACS, who will join Fox Chase and the Temple Health community this summer. In his new role at Fox Chase, Simhan will serve as professor and director of Reconstructive Urology in the Division of Urology and Urologic Oncology. He will also serve as the fellowship director for the Fox Chase Reconstructive Urology fellowship.

Fox Chase nurses attend the 47th annual Oncology Nursing Society (ONS) Congress in Anaheim, California
July 21, 2022

Fox Chase Nurses Experience Inspiring Work at Annual ONS Congress

PHILADELPHIA (July 21, 2022)— Eighteen nurses representing multiple departments at Fox Chase Cancer Center recently attended the 47th annual Oncology Nursing Society (ONS) Congress in Anaheim, Calif. There, they had the opportunity to present research and projects they had conducted over the past year, as well as learn more about oncology nursing from colleagues from around the country.

Steve Sterious, MD, FACS
July 21, 2022

Fox Chase Cancer Center and Temple Health Welcome Urologist Dr. Steve Sterious

PHILADELPHIA (July 21, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Steve Sterious, MD, FACS, who has joined Temple Health and the Fox Chase Division of Urology and Urologic Oncology.

Eric M. Ghiraldi, DO
July 20, 2022

Fox Chase Cancer Center and Temple Health Welcome Urologist Dr. Eric M. Ghiraldi

PHILADELPHIA (July 20, 2022)—Fox Chase Cancer Center is pleased to announce the hiring of Eric M. Ghiraldi, DO, who has joined Temple Health and the Fox Chase Division of Urology and Urologic Oncology.

Pages

Connect with Fox Chase